Ankur Narain to Spondylolisthesis
This is a "connection" page, showing publications Ankur Narain has written about Spondylolisthesis.
Connection Strength
0.934
-
Narain AS, Haws BE, Jenkins NW, Parrish JM, Block AM, Lamoutte EH, Karmarkar SS, Singh K. Diabetes Does Not Increase Complications, Length of Stay, or Hospital Costs After Minimally Invasive Transforaminal Lumbar Interbody Fusion. Clin Spine Surg. 2020 08; 33(7):E307-E311.
Score: 0.659
-
Hijji FY, Narain AS, Bohl DD, Yom KH, Kudaravalli KT, Lopez GD, Singh K. Risk Factors Associated With Failure to Reach Minimal Clinically Important Difference in Patient-reported Outcomes Following Minimally Invasive Transforaminal Lumbar Interbody Fusion for Spondylolisthesis. Clin Spine Surg. 2018 02; 31(1):E92-E97.
Score: 0.138
-
Ahn J, Massel DH, Mayo BC, Hijji FY, Narain AS, Aboushaala K, Bohl DD, Elboghdady IM, DiBattista JV, Singh K. The Utility of Routinely Obtaining Postoperative Laboratory Studies Following a Minimally Invasive Transforaminal Lumbar Interbody Fusion. Clin Spine Surg. 2017 Dec; 30(10):E1405-E1410.
Score: 0.137